Neurotherapeutics

, Volume 14, Issue 3, pp 728–733

Antidepressant Actions of Ketamine Mediated by the Mechanistic Target of Rapamycin, Nitric Oxide, and Rheb

Review

Abstract

The weeks/months it takes for traditional antidepressants to act pose an obstacle in the management of depression. Ketamine’s prompt and sustained antidepressant effects constitute a major advance. Multiple studies implicate glutamatergic signaling to protein synthesis machinery and synapse formation in ketamine’s antidepressant effects. Here we review evidence linking ketamine to glutamate receptor subtypes and protein homeostasis. We describe a signaling cascade wherein nitric oxide drives the formation of a ternary protein complex comprised of glyceraldehyde 3-phosphate dehydrogenase, seven in absentia homolog 1, and Ras homolog enriched in brain downstream of the glutamate N-methyl-D-aspartate receptor. Seven in absentia homolog 1 ubiquitylates and degrades Ras homolog enriched in brain leading to inhibition of mechanistic target of rapamycin. Ketamine inhibits this molecular cascade leading to activation of mechanistic target of rapamycin and, in turn, to antidepressant actions.

Keywords

Ketamine Nitric oxide Glutamate receptor GAPDH Rheb mTOR 

Supplementary material

13311_2017_540_MOESM1_ESM.pdf (1.2 mb)
Required Author Forms Disclosure forms provided by the authors are available with the online version of this article. (PDF 1224 kb)

Copyright information

© The American Society for Experimental NeuroTherapeutics, Inc. 2017

Authors and Affiliations

  1. 1.The Solomon H. Snyder Department of NeuroscienceJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of Psychiatry and Behavioral SciencesJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of Pharmacology and Molecular SciencesJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations